Your browser doesn't support javascript.
loading
Consumer protection provided by the European medical device and cosmetic legislation for condoms and lubricants.
Desmedt, B; Vanhamme, M; Vanhee, C; Rogiers, V; Deconinck, E.
Afiliación
  • Desmedt B; Medicines and Health Products, Sciensano, Juliette Wytsmanstraat 14, 1050, Brussels, Belgium. Electronic address: Bart.desmedt@sciensano.be.
  • Vanhamme M; Medicines and Health Products, Sciensano, Juliette Wytsmanstraat 14, 1050, Brussels, Belgium.
  • Vanhee C; Medicines and Health Products, Sciensano, Juliette Wytsmanstraat 14, 1050, Brussels, Belgium.
  • Rogiers V; Department of In Vitro Toxicology and Dermato-Cosmetology, Vrije Universiteit Brussel, Laarbeeklaan 103, 1090, Brussels, Belgium.
  • Deconinck E; Medicines and Health Products, Sciensano, Juliette Wytsmanstraat 14, 1050, Brussels, Belgium.
Regul Toxicol Pharmacol ; 103: 106-112, 2019 Apr.
Article en En | MEDLINE | ID: mdl-30659873
Personal lubricants and lubricants used in condoms contain a number of ingredients which are also present in cosmetic products. These have to comply to the medical device regulation (745/2017) which should provide the same level of consumer protection, if not more, as foreseen in the legal framework of cosmetics (1223/2009). In the current study we developed an analytical method capable of identifying and quantifying 15 ingredients, commonly found in lubricants and cosmetics. Based upon their most important toxicological endpoint, the substances involved were grouped in three toxicological classes provoking either irritation, contact allergic dermatitis or systemic toxicity. The method was applied on 30 condoms and 54 personal lubricants present on the EU market. Their safety was assessed using the same reasoning as commonly applied for cosmetic ingredients. Higher mucosae susceptibility, the main exposed area for lubricants, was taken into account in this assessment. The results show that the majority of the products studied are safe. Nevertheless, for some products the safety could not be confirmed. The results also highlight the fact that there is no consensus for a number of ingredients, used as well in cosmetics as in medical devices. Alignment between both legislations would improve the safety of these products and further raise the general level of consumer protection.
Asunto(s)
Palabras clave

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Condones / Seguridad de Productos para el Consumidor / Cosméticos / Unión Europea / Lubricantes Tipo de estudio: Etiology_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Regul Toxicol Pharmacol Año: 2019 Tipo del documento: Article

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Condones / Seguridad de Productos para el Consumidor / Cosméticos / Unión Europea / Lubricantes Tipo de estudio: Etiology_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Regul Toxicol Pharmacol Año: 2019 Tipo del documento: Article